Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging

@inproceedings{Fangberget2010NeoadjuvantCI,
  title={Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging},
  author={Anne Fangberget and Line B. Nilsen and Knut H{\aa}kon Hole and Marit Muri Holmen and Olav Engebraaten and Bj\orn Naume and H. Smith and Dag Rune Olsen and Therese Seierstad},
  booktitle={European Radiology},
  year={2010}
}
To explore the predictive value of MRI parameters and tumour characteristics before neoadjuvant chemotherapy (NAC) and to compare changes in tumour size and tumour apparent diffusion coefficient (ADC) during treatment, between patients who achieved pathological complete response (pCR) and those who did not. Approval by the Regional Ethics Committee and written informed consent were obtained. Thirty-one patients with invasive breast carcinoma scheduled for NAC were enrolled (mean age, 50.7… CONTINUE READING